ACIP: Health workers, long-term care residents first tier for COVID-19 vaccine
December 2, 2020
State health departments are expected to rely on the recommendation, but ultimately can make their own decisions on how to allocate vaccine in their states.
Moderna filing for FDA emergency COVID-19 vaccine approval, reports 94.1% efficacy
November 30, 2020
Vaccine efficacy remained consistent across different groups analyzed by age, race/ethnicity, and gender.
CDC panel delves into priorities for COVID vaccine distribution
November 25, 2020
The meeting served as a forum for experts to discuss the thorny issues ahead.
FDA authorizes baricitinib combo for COVID-19
November 20, 2020
The combination treatment is meant for patients who need supplemental oxygen, mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
FDA approves first at-home COVID-19 test kit
November 19, 2020
The Lucira COVID-19 All-In-One Test-Kit is a single-use test that has a nasal swab to collect samples for people ages 14 and older.
Nearly 10% of hospitalized patients with COVID-19 later readmitted
November 12, 2020
The short interval before readmission suggests that patients are probably not suffering a relapse, but more likely experienced some adverse event, such as difficulty breathing.
FDA grants emergency use authorization to Lilly’s antibody COVID-19 therapy
November 10, 2020
“We have supplies to distribute now. Product distribution will begin this week.”
COVID-19 vaccine standards questioned at FDA advisory meeting
October 23, 2020
Speakers asked for data showing COVID-19 vaccines can prevent serious illness and urged transparency about the agency’s deliberations for each product to be considered.
CDC expands definition of COVID-19 exposure from ‘close contact’
October 23, 2020
Four factors associated with higher risk for transmission are the proximity of each encounter, its duration, whether an interaction takes place indoors or outdoors, and the number of people encountered.
FDA approves remdesivir, first treatment for COVID-19
October 22, 2020
The FDA also issued a new EUA for remdesivir allowing treatment of hospitalized pediatric patients younger than 12 weighing at least 3.5 kg.